IP portfolios: the five biggest headaches for in-house counsel
In-house counsel face daily challenges when managing and maintaining their IP portfolios. LSIPR asked two in-house counsel for the biggest challenges they face when managing and maintaining their IP portfolios. Here are the five things we learned.
Latest news
Merck & Co in $2.7bn cancer research acquisition
12-12-2019
Merck & Co has announced its acquisition of cancer research biotech ArQule in a $2.7 billion deal.
Sanofi buys Synthorx for $2.5 billion
10-12-2019
50 Key Influencers In The Life Sciences
- LSIPR 50 2018: Robert Nelsen 05-09-2018
- LSIPR 50 2018: Stephen Knight 04-09-2018
Regions
Sectors
